InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.56
(
-0.11%
)
US TECH 100
19,469.20
(
-0.14%
)
Dow Jones
41,868.03
(
-0.44%
)
Brent Oil
75.05
(
1.31%
)
Bitcoin
67,816.24
(
-1.35%
)
Post# of 253523
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Bio_pete

Send PM Follow Ignore
Followers 17
Posts 1580
Boards Moderated 0
Alias Born 02/07/2007

Bio_pete

Re: tony111 post# 57783

Saturday, 01/19/2008 9:14:19 PM

Saturday, January 19, 2008 9:14:19 PM

Post# of 253523
ZGEN, I think it has to do with the projected sales of rthrombin in 2008. Analysts have been decreasing their sales estimates and it takes awhile for any new product to capture the market. Alot of investors believe they can buy ZGEN in a yr. for the same price so why risk capital in this market. If rthrombin does $40 million in sales for 2008 does ZGEN deserve a $20 stock price?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up